NPCE: Neuropace Inc
NPCE exchange rate has changed by -1.85% for today. During the day, the instrument was traded at a low of 16.2400 and at a high of 16.8300.
Follow Neuropace Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NPCE News
- NeuroPace stock rises on positive NAUTILUS trial results, UBS reiterates Buy
- NeuroPace reports 77% seizure reduction in epilepsy device trial
- Medicare boosts reimbursement for NeuroPace’s epilepsy treatment system
- Cantor Fitzgerald reiterates Overweight rating on NeuroPace stock
- Micron, Eli Lilly among market cap stock movers on Wednesday
- Micron and McDonald’s among market cap stock movers on Wednesday
- NeuroPace stock price target raised to $19 by Leerink on strong Q3 results
- Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday - Babcock & Wilcox (NYSE:BW), Digital Turbine (NASDAQ:APPS)
- NeuroPace stock rises as Cantor Fitzgerald reiterates Overweight rating
- NeuroPace, Inc. (NPCE) Q3 2025 Earnings Call Transcript
- NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates
- NeuroPace stock remains Cantor Fitzgerald’s top pick for 2025
- NeuroPace stock price target lowered to $13 by Wolfe Research
- NeuroPace stock price target lowered to $15 by Wells Fargo on wider loss forecast
- NeuroPace Revenue Jumps 22 Percent in Q2
- NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript
- NeuroPace, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:NPCE)
- Earnings call transcript: Neuropace Q2 2025 sees revenue rise; stock gains 2.7%
- NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates
- Neuropace earnings missed by $0.04, revenue topped estimates
- Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates
- PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates
- Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates
- AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
Frequently Asked Questions
What is NPCE stock price today?
Neuropace Inc stock is priced at 16.4700 today. It trades within 16.2400 - 16.8300, yesterday's close was 16.7800, and trading volume reached 234. The live price chart of NPCE shows these updates.
Does Neuropace Inc stock pay dividends?
Neuropace Inc is currently valued at 16.4700. Dividend policy depends on the company, while investors also watch 55.67% and USD. View the chart live to track NPCE movements.
How to buy NPCE stock?
You can buy Neuropace Inc shares at the current price of 16.4700. Orders are usually placed near 16.4700 or 16.4730, while 234 and -1.14% show market activity. Follow NPCE updates on the live chart today.
How to invest into NPCE stock?
Investing in Neuropace Inc involves considering the yearly range 9.2200 - 17.2200 and current price 16.4700. Many compare 2.04% and 55.67% before placing orders at 16.4700 or 16.4730. Explore the NPCE price chart live with daily changes.
What are Neuropace Inc stock highest prices?
The highest price of Neuropace Inc in the past year was 17.2200. Within 9.2200 - 17.2200, the stock fluctuated notably, and comparing with 16.7800 helps spot resistance levels. Track Neuropace Inc performance using the live chart.
What are Neuropace Inc stock lowest prices?
The lowest price of Neuropace Inc (NPCE) over the year was 9.2200. Comparing it with the current 16.4700 and 9.2200 - 17.2200 shows potential long-term entry points. Watch NPCE moves on the chart live for more details.
When did NPCE stock split?
Neuropace Inc has gone through stock splits historically. These changes are visible in , 16.7800, and 55.67% after corporate actions.
- Previous Close
- 16.7800
- Open
- 16.6600
- Bid
- 16.4700
- Ask
- 16.4730
- Low
- 16.2400
- High
- 16.8300
- Volume
- 234
- Daily Change
- -1.85%
- Month Change
- 2.04%
- 6 Months Change
- 55.67%
- Year Change
- 55.67%
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- $-52.828 B
- Fcst
- $-103.544 B
- Prev
- $-59.265 B
- Act
- $289.305 B
- Fcst
- Prev
- $280.921 B
- Act
- $342.133 B
- Fcst
- Prev
- $340.185 B
- Act
- 236 K
- Fcst
- 196 K
- Prev
- 192 K
- Act
- 1.838 M
- Fcst
- 1.925 M
- Prev
- 1.937 M
- Act
- 4.773%
- Fcst
- Prev
- 4.694%